Incyte Corporation (NASDAQ: INCY) announced that the U.S. Food and Drug Administration has approved Jakafi XR (ruxolitinib) extended-release tablets for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA